Bruker Co. (NASDAQ:BRKR) Receives Average Rating of “Hold” from Analysts

Bruker Co. (NASDAQ:BRKR) has been given a consensus recommendation of “Hold” by the seven analysts that are currently covering the company, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and four have issued a buy recommendation on the company. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is $84.86.

A number of analysts recently issued reports on the company. Citigroup boosted their price target on Bruker from $80.00 to $95.00 and gave the company a “buy” rating in a report on Wednesday, February 14th. JPMorgan Chase & Co. upgraded Bruker from a “neutral” rating to an “overweight” rating and raised their price target for the company from $60.00 to $90.00 in a research note on Wednesday, February 14th. Stifel Nicolaus upped their price objective on shares of Bruker from $63.00 to $81.00 and gave the stock a “hold” rating in a research note on Wednesday, February 14th. UBS Group raised their target price on shares of Bruker from $94.00 to $102.00 and gave the company a “buy” rating in a research report on Friday, March 1st. Finally, The Goldman Sachs Group lifted their price target on shares of Bruker from $66.00 to $74.00 and gave the stock a “sell” rating in a report on Wednesday, April 10th.

Insiders Place Their Bets

In other news, Director Hermann Fritz Requardt sold 15,000 shares of the firm’s stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $90.06, for a total value of $1,350,900.00. Following the completion of the transaction, the director now directly owns 23,147 shares in the company, valued at $2,084,618.82. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 28.20% of the stock is currently owned by insiders.

Institutional Trading of Bruker

A number of hedge funds and other institutional investors have recently made changes to their positions in BRKR. Lindbrook Capital LLC boosted its position in Bruker by 68.2% in the 4th quarter. Lindbrook Capital LLC now owns 360 shares of the medical research company’s stock worth $26,000 after purchasing an additional 146 shares in the last quarter. Zions Bancorporation N.A. purchased a new stake in Bruker during the first quarter worth $26,000. Rise Advisors LLC acquired a new stake in Bruker during the first quarter valued at $27,000. Altshuler Shaham Ltd purchased a new position in Bruker in the fourth quarter valued at $27,000. Finally, Neo Ivy Capital Management acquired a new position in shares of Bruker in the fourth quarter worth about $30,000. Institutional investors and hedge funds own 79.52% of the company’s stock.

Bruker Trading Down 1.0 %

BRKR stock opened at $77.76 on Monday. Bruker has a one year low of $53.79 and a one year high of $94.86. The company has a market capitalization of $10.71 billion, a PE ratio of 26.63, a price-to-earnings-growth ratio of 1.97 and a beta of 1.17. The company’s 50 day moving average price is $87.78 and its two-hundred day moving average price is $74.14. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.99 and a current ratio of 1.80.

Bruker (NASDAQ:BRKR) last released its quarterly earnings data on Tuesday, February 13th. The medical research company reported $0.70 EPS for the quarter, topping the consensus estimate of $0.65 by $0.05. The firm had revenue of $844.50 million for the quarter, compared to the consensus estimate of $809.35 million. Bruker had a return on equity of 29.94% and a net margin of 14.41%. The company’s quarterly revenue was up 19.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.74 earnings per share. As a group, analysts predict that Bruker will post 2.74 earnings per share for the current fiscal year.

Bruker Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 15th. Investors of record on Friday, March 1st were paid a $0.05 dividend. The ex-dividend date was Thursday, February 29th. This represents a $0.20 dividend on an annualized basis and a yield of 0.26%. Bruker’s dividend payout ratio (DPR) is 6.85%.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.